Oncology Letters · 2012 · 25 citations · 10 references
MedicineGeneticsOncologyCarcinogenesisMolecular OncologyOncogenesCancer Molecular PathologyHepatocellular CarcinomaLiver CancerMalignant NeoplasmsOncogene MutationsRas Family OncogenesAberrant Ras ActivationCancer Mutation AnalysisCodon 61 MutationsGenetic Mutation FrequencyMutationMutation Frequency MeasurementOncogenic Ras MutationsRas-driven Tumorigenesis
The aim of this study was to investigate the correlation between H-ras mutation and primary hepatocellular carcinoma (HCC) and to describe the role of H-ras mutation in carcinogenesis. Clinical samples of 69 patients were collected and the expression levels of H-ras in HCC and the surrounding normal tissues were examined using HotStarTaq PCR. H-ras mutation was further analyzed using the PCR direct sequencing method. The results showed that H-ras mutation was present in 49 samples (49/69, 71.01%), of which 19 had codon 40 mutated from CTA to CTG and 30 had codon 61 mutated from GGC to AGC. By contrast, only 2 mutations were found in the normal tumor-adjacent tissues. The H-ras mutation rate in the high-risk of metastatic recurrence group was markedly higher than that in the low-risk group (P<0.01). The H-ras mutation rate in patients with metastatic recurrence during postoperative follow-up was also significantly higher than that in patients without metastatic recurrence (P<0.01). Based on the above results, the H-ras mutation frequency in cancer tissues is markedly higher compared with that in normal tissues. H-ras mutation may play an important role in the genesis and development of HCC and may serve as a reliable marker for individual comprehensive therapy in HCC.
10
Analysis of Binding Site Hot Spots on the Surface of Ras GTPase
Greg Buhrman, Casey M. O’Connor, Brandon S. Zerbe et al. · Journal of Molecular Biology · 2011 · 161 citations
The Anti-inflammatory TIPE2 Is an Inhibitor of the Oncogenic Ras
Yael Gus‐Brautbar, Derek Johnson, Li Zhang et al. · Molecular Cell · 2012 · 127 citations · Full text
Medicine, Cell Biology, Oncology +14
BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases
Mark J. Hoenerhoff, Isabel Chu, Daniel Barkan et al. · Oncogene · 2009 · 100 citations · Full text
Medicine, Cancer Biology, Oncology +14
Sandra Régina, Jérôme Rollin, Claire Bléchet et al. · Journal of Thoracic Oncology · 2008 · 74 citations · Full text